Kaiku Health welcomes Professor Vesa Kataja as new Chief Medical Officer

Kaiku Health has appointed Professor Vesa Kataja as the Chief Medical Officer of Kaiku Health. He has over 25 years of experience in scientific research as well as in clinical work in the in the field of clinical oncology. Prof. Kataja has been an active member of ESMO since 1996 and he is also a member of several national cancer care boards and faculties in an advisory role. Prof. Kataja will join  the team full-time in February 2020.

Kaiku Health is a Debiopharm Innovation Fund portfolio company.

Link to Kaiku Health’s announcement